tiprankstipranks
Advertisement
Advertisement

Embry Holdings flags narrower 2025 loss on reduced impairments and FX gain

Story Highlights
  • Embry Holdings expects its 2025 shareholder loss to narrow to HK$250-260 million from HK$373 million in 2024, mainly due to lower non-recurring, non-cash charges.
  • Reduced impairments on production bases and investment properties plus a swing to a Renminbi-driven FX gain ease balance-sheet pressure, though the group remains loss-making and results are preliminary.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Embry Holdings flags narrower 2025 loss on reduced impairments and FX gain

Meet Samuel – Your Personal Investing Prophet

Embry Holdings Limited ( (HK:1388) ) has shared an announcement.

Embry Holdings Limited has warned that it expects to post a reduced loss attributable to shareholders of about HK$250 million to HK$260 million for the year ended 31 December 2025, narrowing from a loss of roughly HK$373 million a year earlier. The improvement is mainly driven by lower non-recurring, non-cash charges including smaller impairments on property, plant and equipment and investment properties, a reduced write-down on a Shenzhen relocation asset and a swing to a net foreign exchange gain due to Renminbi appreciation, although the group remains in the red and final audited figures may still differ.

The group expects to recognise around HK$40 million in impairment on property, plant and equipment for 2025 versus HK$119 million in 2024, reflecting substantial write-downs already taken on its Shandong and Changzhou production bases last year. It will also book a smaller decline in investment property values and related asset impairments, alongside a roughly HK$4 million foreign exchange gain instead of a prior HK$6 million loss, signaling some easing of balance-sheet pressure but leaving investors cautioned that the business has yet to return to profitability and that the announced figures remain preliminary.

The most recent analyst rating on (HK:1388) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Embry Holdings Limited stock, see the HK:1388 Stock Forecast page.

More about Embry Holdings Limited

Embry Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands that operates through subsidiaries in the Chinese Mainland and Hong Kong. The group’s core business is in branded intimate apparel and related products, supported by production bases in locations such as Shandong and Changzhou and investment properties in major cities including Shanghai, Changzhou, Shenzhen and Hong Kong.

Average Trading Volume: 60,767

Technical Sentiment Signal: Sell

Current Market Cap: HK$164.7M

For a thorough assessment of 1388 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1